2019 - NOW
Built on precision molecular diagnostics, XenoHelix covers the full in vitro diagnostics cycle, from development and clinical trials
to regulatory approval and mass production.
2025 - PRESENT
26. 07
Closed KRW 4.5 billion Series B (KRW 3 billion strategic, KRW 1.5 billion financial)
26. 03
Launched Ex Heal and miPDRN cosmetics
26. 02
Secured KRW 3 billion in strategic investment
25. 09
Launched Ex Heal Booster
2023 - 2024
24. 11
Obtained export manufacturing approval for in vitro diagnostic (IVD) devices
24. 09
Built a smart factory system
24. 07
Selected for the Ministry of Science and ICT's Bio & Medical Technology Development Program (IVD for metabolic fatty liver disease; KRW 6 billion)
24. 06
Selected for the Ministry of SMEs and Startups' Post-TIPS Program (KRW 300 million)
24. 02
Completed IVD manufacturing notification for the XENOPURE gDNA Purification Kit
23. 12
Secured Series B investment from Severance MD Private Equity Fund No. 1 & 2
23. 10
Obtained IRB approval for the pivotal clinical trial of XENO-Q (Parkinson's disease diagnostic)
23. 09
Secured Series B investment from KB New Deal Innovation Fund
Signed a product supply agreement with a Taiwanese distributor
2021 - 2022
22. 12
Won the Grand Prize (Minister of Science and ICT Award) at the Uni-Tec Demo Day
22. 09
Obtained an IVD manufacturing license from the Ministry of Food and Drug Safety (MFDS)
22. 07
Selected for the Technical Support Program of the 2022 Free Economic Zone Innovation Ecosystem Creation Project
22. 06
Selected for the 2022 Biosafety Standard Research Facility Construction Support Program
Obtained ISO 13485:2016 certification
22. 04
Obtained GMP certification for IVD devices
Selected for the 2022 Pan-Government Medical Device Development Project (KRW 4 billion)
22. 01
Selected for the 2022 BIG3 Innovative Startup Package
21. 12
Won the Grand Prize (Minister of SMEs and Startups Award) at the Dae-Star Problem Solver Platform
Won the Grand Prize at the Round 3 Competition (Bio-Health)
21. 09
Selected as an Outstanding Venture Business
21. 07
Secured A-Bridge investment from Partners No. 9 Investment Association
Secured A-Bridge investment from Almus Growth Support Investment Association No. 1
21. 06
Signed an industry-academia cooperation agreement with Incheon JEI University
21. 01
Selected for the 2021 BIG3 Innovative Startup Package
2019 - 2020
20. 12
Selected for the Senior Workforce Recruitment Support Program
20. 09
Selected for the SME Tech Innovation R&D Program
Launched XENOPURE™
20. 06
Opened the Seoul branch
20. 05
Selected by the Ministry of SMEs and Startups as a BIG3 Innovative Growth Startup
Secured Series A investment from KB Growth Support Fund
20. 03
Certified as an LMO Biosafety Level 2 (BL2) Facility
19. 12
Certified as a Corporate R&D Center by the Korea Industrial Technology Association (KOITA)
19. 11
Opened the Songdo branch
19. 10
Selected for the Tech Incubator Program for Startups (TIPS)
Became a regular member of the Korea Venture Business Association (KOVA)
Registered as a Research Institute Company
19. 09
Certified as a Venture Business by KOTEC
Certified as a Venture Business by the Korea Technology Finance Corporation (KOTEC)
19. 08
Selected for the Early Startup Package (Ministry of SMEs and Startups / KISED)
19. 07
Founded XenoHelix Co., Ltd. as a subsidiary of Yonsei University Technology Holdings
